Lifevantage Corp · Drugmakers

LFVN

Low riskNext report: In 6 days (est.)

View price ↗

The short version

A high-quality, profitable business with shrinking sales. Institutions are trimming.

Going well

Profitable every year for 10 years
Sales up 14% last year
Brings in more cash than it spends

Watch out for

Sales down 23% in the latest quarter vs a year ago

Money moves

No insider buying or selling in the last 30 days
Institutions cut 22% from their holdings in the quarter ending June 2026 (41 bought, 61 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$5.80-1.2% that day

Company value: $73M; Share price times all shares
Price vs profit (P/E): 14.5x; You pay about $14 for each $1 of yearly profit
Price vs sales: 0.40x; Company value is 0.40 times a year of sales
Dividend yield: 2.8%; Yearly dividend as a share of today's price
Cash vs value: 21%; Cash as a share of company value

From LFVN's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26 (worked out from yearly totals)

$42.4M-23% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $182.6M, down 20% from the 12 months before. Over 5 years, sales shrank about 0.4% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of LFVN. Starting points are the company's recent numbers.

Sales growth-10% a yearRecently: -20% a yearProfit margin3%Last 12 months: 2.8%P/E at the end14xToday: 14.5x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$108M

Profit in 5 years$3M

Price these guesses point to$3.61-38% vs $5.80 todayAbout -9.0% a year, before dividends

What today's price needs: with a 3% margin and a 14x P/E, sales could shrink about 1.1% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Word of mouth

Updated daily

People looking up the company, yesterday: 1.5x normal; 33 views vs about 22 on a usual day

Forum talk counts mentions of LFVN in popular online stock forums, a slice of the internet rather than all of it. Company lookups show interest in the company itself, which can come from news that isn't about the stock. Attention isn't quality.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

6/7Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.31.2%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.4.3%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$10.5M
PassShare count not growingNot diluting owners. Falling means buybacks.-0.6% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.80.4%

Revenue: $228.5M; +14.2% vs prior year
5-year growth: -0.4%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 2.03x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.